EDGAR Filing Documents for 0001493152-17-008881

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-17-008881

Filing Date

2017-08-10

Accepted

2017-08-10 16:12:10

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	1037230
2		ex10-7.htm	EX-10.7	146152
3		ex10-8.htm	EX-10.8	71278
4		ex10-9.htm	EX-10.9	72735
5		ex10-10.htm	EX-10.10	73732
6		ex10-11.htm	EX-10.11	71997
7		ex31-1.htm	EX-31.1	17684
8		ex31-2.htm	EX-31.2	18896
9		ex32-1.htm	EX-32.1	9475
	Complete submission text file	0001493152-17-008881.txt		5239346

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE FILE	immy-20170630.xml	EX-101.INS	798811
11	XBRL SCHEMA FILE	immy-20170630.xsd	EX-101.SCH	62180
12	XBRL CALCULATION FILE	immy-20170630_cal.xml	EX-101.CAL	80812
13	XBRL DEFINITION FILE	immy-20170630_def.xml	EX-101.DEF	210291
14	XBRL LABEL FILE	immy-20170630_lab.xml	EX-101.LAB	408669
15	XBRL PRESENTATION FILE	immy-20170630_pre.xml	EX-101.PRE	313075

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130

Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042

Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)